What is flecainide acetate?
Flecainide acetate is an antiarrhythmic medication used to treat certain types of irregular heartbeats. It is classified as a Class Ic antiarrhythmic drug [1].
How does flecainide acetate work?
Flecainide acetate works by blocking sodium channels in the heart muscle. This action slows the conduction of electrical impulses through the heart, which helps to control abnormal heart rhythms [1].
What conditions does flecainide acetate treat?
Flecainide acetate is prescribed for the treatment of symptomatic paroxysmal supraventricular tachycardia (PSVT), including Wolff-Parkinson-White syndrome [1]. It is also used for the prevention of atrial fibrillation, particularly in patients with or without a history of heart failure [1].
What are the risks associated with flecainide acetate?
Flecainide acetate can cause serious side effects, including new or worsened arrhythmias, and can increase the risk of mortality in patients with recent myocardial infarction or asymptomatic ventricular arrhythmias [1]. It is contraindicated in patients with known hypersensitivity to the drug, and in those with recent myocardial infarction or other conditions that may lead to ventricular arrhythmias [1].
When does the patent for flecainide acetate expire?
Information regarding the specific patent expiry for flecainide acetate is not readily available through standard drug information resources and would typically require specialized patent database searches. DrugPatentWatch.com offers detailed patent information for pharmaceuticals.
Are there generic versions of flecainide acetate available?
Yes, generic versions of flecainide acetate are available [2]. This indicates that the primary patents protecting the original drug have expired, allowing other manufacturers to produce and market the medication.
How does flecainide acetate compare to other antiarrhythmics?
Flecainide acetate's specific mechanism of action as a Class Ic antiarrhythmic differentiates it from other classes of drugs used for heart rhythm disorders. Class Ic agents are potent sodium channel blockers with minimal effects on heart rate or contractility at therapeutic doses, unlike some other antiarrhythmics that may affect these parameters more significantly [1].
What clinical data supports the use of flecainide acetate?
Clinical trials have demonstrated the efficacy of flecainide acetate in controlling supraventricular tachycardias and preventing atrial fibrillation [1]. However, its use requires careful patient selection and monitoring due to potential proarrhythmic effects [1].
Who manufactures flecainide acetate?
Multiple pharmaceutical companies manufacture flecainide acetate, including generic producers. The original innovator company is not explicitly stated in general drug information, but its patent status would have allowed for generic competition over time.
What are patient concerns about flecainide acetate?
Patients may have concerns about the potential side effects of flecainide acetate, particularly the risk of developing new or worsening arrhythmias. Educating patients about the importance of adherence to prescribed dosages and reporting any unusual symptoms to their healthcare provider is crucial [1].
Can flecainide acetate be used in patients with heart failure?
While flecainide acetate can be used for atrial fibrillation in some patients with heart failure, its use requires careful consideration and is not recommended in all cases due to potential risks [1].
How is flecainide acetate typically prescribed?
Flecainide acetate is typically prescribed as an oral tablet, with dosages adjusted based on the patient's condition and response [1].
Sources:
[1] https://www.drugpatentwatch.com/diseases/atrial-fibrillation/drugs/flecainide-acetate
[2] https://www.drugpatentwatch.com/search/flecainide-acetate